Regular aspirin dose 'could reduce cancer risk'

People in their 40s could reduce their risk of cancer in later life with a regular dose of aspirin, it was claimed today.

Regular aspirin dose 'could reduce cancer risk'

People in their 40s could reduce their risk of cancer in later life with a regular dose of aspirin, it was claimed today.

Taking aspirin for at least 10 years before cancers normally develop would maximise the drug’s effect, scientists from the charity Cancer Research UK said.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited